Highlights
NASDAQ: KNSA       Kiniksa Pharmaceuticals Ltd
Last Price Today's Change   Day's Range   Trading Volume
21.48   -0.41 (1.87%)  21.113 - 22.20  137,823

Overview

 
Avg Volume (4 weeks):361,657
4 Weeks Range:19.635 - 24.70
4 Weeks Price Volatility (%):
36.43%
52 Weeks Range:10.30 - 28.67
52 Weeks Price Volatility (%):
60.86%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, KPL-045, KPL-404 are other monoclonal antibodies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2216  4258  265  3283 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 1.40+0.05 
 WPX 9.43+0.48 
 SOS 6.99+0.30 
 NIO 44.593-5.167 
 RKT 29.45+5.15 
 SNSS 5.32+1.04 
 AAPL 126.179-1.611 
 AMC 8.921-0.259 
 JCS 8.69+3.34 
 F 12.415+0.435